Verify your claims against versioned evidence records with exact reported results and sources.Know what the science actually supports before you trust the answer.
Press Enter ↵ to review claims
Explore by Goal
"The diversity of the phenomena of nature is so great, and the treasures hidden in the heavens so rich, precisely in order that the human mind shall never be lacking in fresh nourishment."
Learta Pervizaj-Oruqaj’s published work (as identifiable from the provided paper list) clusters strongly around lung immunology / macrophage biology and host–pathogen cell-cycle control, with notable contributions spanning high-impact venues (e.g., Nature Communications and Science Immunology)
Cell-cycle modulation in bovine endothelial cells (G1/S arrest signatures, regulator upregulation, HH3 S10 phosphorylation) in Parasitology Research .
Alveolar macrophage lineage/function in lung repair including mechanistic links to Plet1 in viral pneumonia contexts in Nature Communications .
Functional plasticity of alveolar macrophages via efferocytosis (cell type–specific efferocytosis shaping macrophage functional states) in Science Immunology .
Critical caveat: from the information provided here, we can evaluate scientific themes and one raw-data-informed study’s logic, but cannot fully audit authorship contribution depth (e.g., lead vs minor), complete reproducibility, or broader track-record without full-text details for each work.
Long Explanation
Author Review: Learta Pervizaj-Oruqaj
What I can and cannot do with the provided input: I can rigorously assess (i) the scientific coherence of the themes, and (ii) the study strength of the one paper for which detailed raw-data-like extract structure was provided (Parasitology Research, 2020). I cannot fully assess every metric claim (e.g., total works, h-index) because those meta-values were provided via OpenAlex without DOI-backed provenance.
1) Visuals first: evidence density & key reported quantitative signals
Below graphs use only the numerical fields explicitly present in the provided extract for Besnoitia besnoiti–driven endothelial host cell cycle alteration (10.1007/s00436-020-06744-x) .
Figure A — Infection rate across primary BUVEC isolates (MOI 5:1; 24 h p.i.)
Figure B — Reported p-values for selected host cell-cycle regulators (Western blot; 24 h p.i.)
Figure C — Directionality map of reported host cell-cycle marker changes (based on extract text)
2) Scientific focus and publication themes (from provided DOI-identifiable works)
The provided paper list indicates a coherent research program centered on:
Alveolar macrophage biology in lung homeostasis/inflammation resolution and repair—e.g., alveolar macrophage orchestration of lung inflammation/homeostasis .
Macrophage-mediated epithelial repair programs after viral pneumonia with mechanistic mediator emphasis (Plet1) .
Efferocytosis-to-functional-plasticity coupling in alveolar macrophages, relevant to injury resolution and infection risk during resolution phases .
Host cell-cycle control under intracellular parasitism (bovine endothelial cell systems with apicomplexan parasites), including species-specific comparisons .
3) Critical deep-dive: strength analysis of the provided raw-data extract (2020 Parasitology Research)
Problem statement addressed: The study tests whether Besnoitia besnoiti modulates host endothelial cell-cycle progression in bovine cells and how this differs from known effects of Toxoplasma gondii, framed as parasite strategies for intracellular development .
Multi-readout convergence: the extract couples host growth/proliferation measurement, flow-cytometry DNA content phase distribution, western blot cell-cycle regulators (cyclin E1, p27^Kip1; plus unchanged G2/M-related proteins), phospho-histone H3 (S10), and PCNA distribution by confocal .
Marker-specific directionality with selective change: cyclin E1 and p27^Kip1 increase while selected other cycle regulators remain unchanged; this supports patterned host-cycle modulation rather than a generic stress response (though it cannot fully rule out all stress-mediated mechanisms) .
Quantitative signals are present: at least some endpoints have explicit p-values, including cyclin E1 (p=0.00314), p27^Kip1 (p=0.0379), and phospho-H3 S10 (p=0.0017) as provided in the extract .
Primary-cell donor variability: the extract highlights inter-donor variability inherent to primary BUVEC isolates, which can inflate noise or lead to inconsistent phase-distribution outcomes across isolates .
Host vs parasite DNA/phase readout ambiguity: DNA-content flow cytometry can be confounded if parasite-derived DNA materially contributes to measured signals (especially when intracellular parasite load is substantial) .
Temporal resolution limits: measurements are up to 24 h p.i.; if later-cycle effects occur beyond this window, the study could miss them (leading to an incomplete mechanistic picture) .
In vivo generalizability not established: lack of direct in vivo validation limits how confidently one extrapolates from isolated primary endothelial cells to organismal infection dynamics .
P-value/reporting inconsistencies risk: the extract mentions some p-values reported (e.g., p=0.0741) suggesting possible reporting inconsistencies; this is a red flag for interpretability and should be checked against full text tables/figure legends .
Is the conclusion “G1/S arrest” adequately supported?
The extract’s pattern—upregulated cyclin E1 + p27^Kip1, selective preservation of some G2/M regulators, and increased phospho-H3 (S10) plus time-dependent nuclear PCNA distribution peaking at ~12 h—is directionally compatible with a G1/S-restricted disruption of progression, but the extract also flags confounds (host vs parasite DNA in flow, donor variability, parasite load masking, limited time window). Therefore, the best-supported statement from the provided information is: B. besnoiti infection is associated with host cell-cycle regulatory changes consistent with a G1/S-centric arrest signature, with moderate confidence rather than high certainty of strict causality and full stage specificity .
What evidence would disprove or materially change the interpretation?
Demonstrating that DNA-content and phase shifts are largely parasite-DNA driven rather than host-cycle progression changes (e.g., stronger host-parasite discrimination approaches) .
Showing that cyclin E1/p27^Kip1 changes are downstream of generalized toxicity/inflammation rather than specific cell-cycle control mechanisms (requiring additional discriminating markers/controls not assessable from the extract alone) .
Extending timepoints beyond 24 h p.i. to verify whether a later shift occurs that contradicts strict arrest rather than transient modulation .
4) Broader evidence context (selected additional works listed with DOIs)
The following works (from the provided paper list with explicit DOIs) support that the author’s scientific output spans multiple host–pathogen contexts and mechanistic immune/lung biology directions:
Neospora caninum host cell-cycle arrest (Frontiers in Cell and Developmental Biology; 2022) .
Corrigendum exists for the above study, indicating at least one post-publication correction step .
Cell type–specific efferocytosis and macrophage plasticity (Science Immunology; 2025) .
Viral pneumonia repair program tied to Plet1 (an additional 2023 record exists in the list, presented without journal name in the extract) .
5) Epistemic humility: what remains unknown from this input
Even though the themes appear consistent, scientific strength depends on details not included in the extract: sample randomization, blinding, full statistical models, independent replicate definitions, raw figure panels, and whether alternative mechanisms were directly tested.
Also, for corrigenda/administrative corrections, the excerpt does not provide whether conclusions were substantively changed .
6) Practical “how to use this review”
If you want an even more rigorous audit, I recommend pulling each paper’s full-text tables/figures and re-checking: (i) how host vs parasite readouts were separated, (ii) replicate definitions (biological vs technical), (iii) whether confounders were measured and modeled, and (iv) whether claims about arrest type are consistent across all timepoints.
Extract per-DOI endpoint signals from the provided full-texts, then cluster markers into host-cycle stages (G1/S vs S vs G2/M) and visualize pathway-level consistency across infection models using only reported quantitative fields.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
A simple generalized toxicity model (infection just damages cells) explains all observed marker shifts—unlikely because the extract emphasizes selective changes (e.g., cyclin E1/p27^Kip1 up while some G2/M regulators unchanged) and stage-consistent patterns, though confounding cannot be fully excluded from the extract alone.
The cell-cycle effects are purely random statistical fluctuations across donors—unlikely given the reported consistent qualitative directionality and multiple readouts, but donor variability and host/parasite signal confounding are still plausible enough to keep confidence moderate.
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Keep Exploring
Analysis 
Hypothesis Graveyard
Potential Experiments
Discussion